NCT00282906View on ClinicalTrials.gov

FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

October 3, 2005

Primary Completion Date

December 19, 2013

Study Completion Date

August 19, 2014

Conditions
Prostate Cancer
Interventions
DEVICE

hybrid PET-CT imaging system

15 mCi of FDG

Trial Locations (1)

90033

USC/Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT00282906 - FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter